The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-(((4-(3-(3-(tert-Butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-ureido)naphthalen-1-yl)oxy)methyl)pyridin-2-yl)acetamide ID: ALA3781102
PubChem CID: 53391990
Max Phase: Preclinical
Molecular Formula: C33H34N6O3
Molecular Weight: 562.67
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)Nc1cc(COc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1
Standard InChI: InChI=1S/C33H34N6O3/c1-21-10-12-24(13-11-21)39-31(19-29(38-39)33(3,4)5)37-32(41)36-27-14-15-28(26-9-7-6-8-25(26)27)42-20-23-16-17-34-30(18-23)35-22(2)40/h6-19H,20H2,1-5H3,(H,34,35,40)(H2,36,37,41)
Standard InChI Key: VOIHJDKJPGOZPU-UHFFFAOYSA-N
Molfile:
RDKit 2D
42 46 0 0 0 0 0 0 0 0999 V2000
10.3964 -2.6977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3985 -1.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4389 -0.8998 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0998 -0.7454 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7985 -1.4932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4994 -0.7432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2003 -1.4932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8990 -0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6003 -1.4977 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5973 1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5549 3.6021 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8933 3.7570 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8912 5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6747 6.1134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1333 7.5416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6332 7.5468 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1017 6.1218 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.5279 5.6546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.9493 4.2204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.4074 3.8681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.4415 4.9545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.6080 4.6726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0177 6.3934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5597 6.7458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2484 8.7506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0553 8.6218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7330 9.8484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5402 9.7193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -3.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2004 -2.9933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4995 -3.7432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7985 -2.9932 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
2 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 1 0
15 16 2 0
15 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 18 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
26 28 1 0
28 29 2 0
29 23 1 0
20 30 1 0
30 31 1 0
30 32 1 0
30 33 1 0
13 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 38 1 0
38 39 2 0
39 10 1 0
39 34 1 0
7 40 2 0
40 41 1 0
41 42 2 0
42 5 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 562.67Molecular Weight (Monoisotopic): 562.2692AlogP: 7.21#Rotatable Bonds: 7Polar Surface Area: 110.17Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.26CX Basic pKa: 3.94CX LogP: 6.91CX LogD: 6.91Aromatic Rings: 5Heavy Atoms: 42QED Weighted: 0.19Np Likeness Score: -1.46
References 1. Onions ST, Ito K, Charron CE, Brown RJ, Colucci M, Frickel F, Hardy G, Joly K, King-Underwood J, Kizawa Y, Knowles I, Murray PJ, Novak A, Rani A, Rapeport G, Smith A, Strong P, Taddei DM, Williams JG.. (2016) Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant Asthma., 59 (5): [PMID:26800309 ] [10.1021/acs.jmedchem.5b01029 ] 2. (2016) P38 MAP kinase inhibitors,